PRESS RELEASES & STATEMENTS

      • 10 October, 2019

    ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation

    The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”
    Full story
      • 8 October, 2019

    ISSCR Visits Capitol Hill, Washington, DC, U.S.

    The ISSCR led a group of scientists to Washington, DC, U.S. to garner support for policies important to stem cell research and the broader biomedical research community. The scientists met with representatives from 16 Congressional Offices to discuss the protection of fetal tissue research, the need for additional enforcement to curb the marketing and use of unproven products, and the importance of NIH funding for biomedical research.
    Full story
      • 8 October, 2019

    Lawrence Goldstein Policy Fellows Announced

    The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).
    Full story
      • 7 October, 2019

    ISSCR Policy Advocacy in Action

    Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.
    Full story
      • 4 October, 2019

    ISSCR Education Committee Call for Resources

    The ISSCR Education Committee is compiling educational resources on stem cell science and its applications to support the teaching needs of our constituents. To help the Education Committee create the course syllabus, we are asking you for examples of your syllabi on courses related to stem cell biology, translational medicine, and clinical applications.
    Full story
      • 6 September, 2019

    ISSCR Applauds Google’s New Policy Banning Ads on Unproven Therapies

    The International Society for Stem Cell Research (ISSCR) today released the following statement regarding Google’s new policy that bans advertisements from unproven stem cell clinics and other speculative medical interventions.
    Full story
      • 22 August, 2019

    Nominate for ISSCR Awards and Leadership Positions

    The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists and the future of the field, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story
      • 12 August, 2019

    The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions

    The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.
    Full story
      • 9 August, 2019

    Inspiration From the ISSCR 2019 Annual Meeting: Making Meaningful Impacts in 2019 & 2020

    As stem cell researchers, we are in a unique position to make real and meaningful impacts in the world. During my time as ISSCR President my goal, beyond serving ISSCR’s role as the main convener of stem cell science, is to strengthen the society’s voice and influence by expanding on our global policy initiatives and helping foster industry-academic partnerships to accelerate the safe and effective clinical translation of stem cell research.
    Full story
      • 23 July, 2019

    ISSCR 2019 Annual Meeting Wrap-up (with photos!)

    Nearly 4,000 scientists, physicians, and stem cell professionals from across the globe gathered at the ISSCR 2019 Annual Meeting in Los Angeles, CA, a vibrant city with world-class stem cell research, to share their discoveries, enhance their careers, and inspire their science.
    Full story
      • 22 July, 2019

    What I like most about the ISSCR Annual Meeting

    We asked Naomi Koh Belic, a PhD candidate from the University of Technology Sydney, for her perspective as a trainee attending the ISSCR Annual Meeting for the third year. Naomi shares some highlights and tips from ISSCR2019 in Los Angeles.
    Full story
      • 30 June, 2019

    Deepak Srivastava Becomes President of the ISSCR

    The ISSCR is pleased to announce Deepak Srivastava, MD, Gladstone Institutes, as the incoming president of the ISSCR and its board of directors. Srivastava assumed the post immediately following the 17th ISSCR Annual Meeting in Los Angeles, 26-29 June, 2019.
    Full story
      • 26 June, 2019

    The ISSCR Announces Establishment of Lawrence Goldstein Science Policy Fellowship

    The ISSCR honored longtime member Lawrence Goldstein for his years of science policy advocacy, and announced a new program in his name that will train ISSCR members to become stem cell policy advocates. The tribute and introduction of the Lawrence Goldstein Science Policy Fellowship program was part of the opening plenary session of the ISSCR annual meeting, 26-29 in Los Angeles, Calif., U.S.
    Full story
      • 13 June, 2019

    Leading Stem Cell Scientists Present Groundbreaking Research at Annual Meeting

    The International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center, will bring together more than 3,500 scientists, bioethicists, clinicians, industry professionals, and others from over 50 countries to share the latest developments in stem cell science and regenerative medicine.
    Full story
      • 13 June, 2019

    ISSCR Supports Amendment in U.S. Congress to Prevent Fetal Tissue Research Funding Restrictions

    The ISSCR and other medical, scientific, educational, and healthcare groups sent a letter to members of the U.S. Congress supporting an amendment that would prevent the implementation of a new policy to restrict and delay federal funding for fetal tissue research.
    Full story
      • 7 June, 2019

    ISSCR Applauds Landmark Court Ruling in Favor of FDA Regulating Stem Cell Therapies Offered by Florida Clinic

    The ISSCR commends the U.S. District Court ruling that confirms the FDA’s authority to regulate clinics marketing and selling unproven therapies as stem cell products. The clinic, U.S. Stem Cell, has injected cells derived from fat into the eyes of several patients, resulting in at least three being blinded.
    Full story
      • 5 June, 2019

    ISSCR Opposes Health and Human Services Policy Restricting Fetal Tissue Research

    The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding for fetal tissue research in the National Institutes of Health (NIH) intramural research program. This research has long been viewed as good public policy to improve human health and has proceeded with public support.
    Full story
      • 24 May, 2019

    ISSCR Comments on China's Proposed Regulations for Cell Therapies

    The ISSCR has submitted comments to China's National Medical Products Administration regarding China's draft regulations for the Management of Clinical Research and Transformation Applications for Somatic Cell Therapy.
    Full story
      • 24 May, 2019

    How to Prepare for ISSCR 2019: Tips from Your Graduate Student Colleagues

    The annual meeting can be overwhelming, with new scientific discoveries to learn about and colleagues to meet. We asked two trainee members, Kimberley Babos and Louise Menendez, for their thoughts about how they plan ahead to ensure they make the most out of their time at the meeting.
    Full story
      • 20 May, 2019

    ISSCR Applauds Health Canada’s New Policy Statement re Autologous Cell Therapy Products

    The ISSCR welcomes the new policy guidance from Health Canada that clarifies the regulation of autologous cell products in Canada. The new policy guidance aligns Canada’s regulations with the U.S. Food and Drug Administration’s 2017 Regenerative Medicine Framework and the Australian Therapeutic Goods Administration’s 2018 Autologous human cell and tissue product regulations.
    Full story
      • 13 May, 2019

    The Important Role of Patients

    A wide variety of motivations propel us to pursue science careers at the bench or in industry. Often as young adults we’re driven by curiosity and the desire to understand why things work the way they do. One key motivator for many of us is the potential to have a real impact on the lives of patients and their families.
    Full story
      • 10 May, 2019

    ISSCR Commends U.S. House of Representatives Committee for Approval of NIH Funding Bill

    The Appropriations Committee of the U.S. House of Representatives has approved a $2 billion increase for the National Institutes of Health (NIH) and defeated an amendment that would have prohibited federal funding for fetal tissue research.
    Full story
      • 2 May, 2019

    Stem Cell Therapies and Regenerative Medicine Moving Toward the Clinic

    Stem cell research is leading to potential new therapies to treat disease, with several applications in clinical trials or expected to enter trials in the coming months. These new discoveries are transforming how we think of medicine and will be key to discussions at the International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center.
    Full story
      • 8 April, 2019

    Guidelines and Regulations Necessary as Stem Cell Field Advances

    With the rapid growth of the stem cell field and advances in regenerative medicine, it is critically important that researchers earn and retain the public trust. To that end we must operate under agreed-upon guidelines that ensure ethical activities, transparency, and sound science.
    Full story
      • 29 March, 2019

    ISSCR Comments on New Biomedical Technology Regulations in China

    In response to draft regulations in China on gene editing and other potentially risky biomedical technologies, the ISSCR has submitted comments to the the country's National Health Commission Medical and Medical Administration Bureau.
    Full story
      • 13 March, 2019

    ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research

    The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos.
    Full story
      • 11 March, 2019

    ISSCR 2019 Election Results

    ISSCR has elected its next leadership slate, with leaders beginning their terms after the 2019 annual meeting. On behalf of all members, we extend congratulations to newly-elected officers Melissa Little, vice president; and Kenneth Zaret, treasurer, and re-appointed board members Marianne Bronner, Valentina Greco, and Arnold Kriegstein.
    Full story
      • 8 March, 2019

    Sharing Excellent Science and Growing Personal Networks

    Each year our annual ISSCR meeting showcases for the world the potential of stem cell science and advances already underway that are changing the face of human healthcare. We highlight the latest innovative research and scientific developments that are propelling the field forward in a variety of ways. ISSCR 2019 in Los Angeles is a terrific opportunity to inspire us with research at the leading-edge of scientific discovery
    Full story
      • 25 February, 2019

    Progress in Stem Cell Science & Regenerative Medicine On Tap in Los Angeles, 26-29 June

    Top scientists and researchers from academia, medicine, and industry will gather to share groundbreaking stem cell science and its translation to clinical application at the annual meeting of the International Society for Stem Cell Research (ISSCR), 26-29 June in Los Angeles, Calif.
    Full story
      • 22 February, 2019

    Advocating for Science and Research

    Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'
    Full story
      • 8 February, 2019

    ISSCR Announces 2019 Award Recipients

    The ISSCR announces the recipients of its 2019 Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award. Awardees will be recognized at the ISSCR annual meeting, 26-29 June, in Los Angeles, Calif., U.S.
    Full story
      • 8 February, 2019

    New Voices, Breakthrough Science at ISSCR 2019

    If you’re an enterprising stem cell scientist with exciting work to publish this year, the ISSCR annual meeting in Los Angeles, 26-29 June, is the place to take the stage and showcase your science to colleagues and the field. We’ve developed a new program structure this year that dedicates 15 plenary speaking spots to abstract-selected speakers, to showcase the talents of the next generation of scientists.
    Full story
      • 21 January, 2019

    ISSCR Introduces Chief Operating Officer Keith Alm

    Keith Alm joined the ISSCR as chief operating officer in January 2019, after serving as a brand strategist and consultant for the society for nearly a decade. He’s worked with many of the organization's leaders on strategic positioning, communications, and partnerships.
    Full story
      • 4 January, 2019

    Standing Up for Scientific Research

    The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.
    Full story
      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 5 December, 2018

    2018 ISSCR Year in Review

    Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 November, 2018

    New Perspectives in Stem Cell Reports

    In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.
    Full story
      • 12 November, 2018

    Convergence of Stem Cell Science and Medicine

    Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story
      • 5 October, 2018

    Developing Trainees, Expanding Horizons

    I take seriously my responsibility to support and nurture future generations of stem cell scientists. Indeed, it is critical for all of us in this evolving field to help trainees and others coming up in the field, to ensure they have opportunities to learn, grow, make connections, and share their science.
    Full story
      • 2 October, 2018

    ISSCR Comments on Horizon Europe

    The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.
    Full story
      • 2 October, 2018

    ISSCR Voice is Heard on Capitol Hill

    In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.
    Full story
      • 27 September, 2018

    ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research

    The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.
    Full story
      • 10 September, 2018

    ISSCR Journal Focuses on Women in Stem Cell Science; Reflections by CEO Nancy Witty

    The ISSCR has always had strong female leaders, and many of them are featured in the September and October editions of Stem Cell Reports.
    Full story
      • 6 September, 2018

    Energizing for Renewed Focus

    Many of us find time in the summer to reflect on work and recharge our batteries. Vacations, visits with friends, and time with family all help get away from everyday concerns in the lab and gain some perspective to inform the scientific path for the year ahead.
    Full story
      • 23 August, 2018

    Nominate for ISSCR Awards and Leadership Positions

    The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story
      • 17 July, 2018

    2018 ISSCR Annual Meeting Wrap-up

    The ISSCR 2018 Annual Meeting went “down under” to Melbourne, Australia where 3,000 stem cell scientists, clinicians, and professionals from 52 countries gathered to share their latest research, network with colleagues, and explore the latest technologies driving the field forward.
    Full story
JMosher Pic

Jack Mosher

Scientific Affairs Manager +1 224-601-5000 (o)

Email Jack